Bio-Techne Corp (NASDAQ:TECH) shares, rose in value on Wednesday, May 07, with the stock price up by 2.16% to the previous day’s close as strong demand from buyers drove the stock to $48.75.
Actively observing the price movement in the last trading, the stock closed the session at $47.72. The PE ratio was 49.55 over 12-month period. Referring to stock’s 52-week performance, its high was $85.57, and the low was $46.01. On the whole, TECH has fluctuated by -6.81% over the past month.
With the market capitalization of Bio-Techne Corp currently standing at about $7.71 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 0.32, with its dividend yield at 0.66%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 1.23B, with a low estimate of 313.6M and a high estimate of 322.7M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 317.37M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TECH’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 4.22, with the price of TECH currently trading nearly -2.60% and -12.68% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.89, while the 7-day volatility ratio is showing 4.62% which for the 30-day chart, stands at 5.37%. Furthermore, Bio-Techne Corp (TECH)’s beta value is 1.42, and its average true range (ATR) is 2.54.
A comparison of Bio-Techne Corp (TECH) with its peers suggests the former has fared considerably weaker in the market. TECH showed an intraday change of 2.16% in last session, and over the past year, it shrunk by -36.93%%.
Data on historical trading for Bio-Techne Corp (NASDAQ:TECH) indicates that the trading volumes over the past 3 months, they’ve averaged 2.02 million. According to company’s latest data on outstanding shares, there are 157.92 million shares outstanding.
Nearly 1.12% of Bio-Techne Corp’s shares belong to company insiders and institutional investors own 100.57% of the company’s shares. The stock has fallen by -32.32% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TECH stock heading into the next quarter.
